Cervicovaginal lavages from 752 pregnant women at term were investigated by polymerase chain reaction to evaluate human papillomavirus (HPV) infection prevalences and were compared with cervicovaginal samples from two series of nonpregnant subjects (504 healthy women attending a family planning service and 560 symptomatic patients attending a vaginitis outpatient service). The odds ratios (ORs) of HPV infection were computed by conditional logistic regression analysis on age-matched sets. In pregnant women, the overall risk of HPV infection was about the same as in nonpregnant healthy subjects (adjusted OR, 0.90; 95% confidence interval [CI], 0.51-1.58) and was 50% less than in patients with symptomatic vaginitis (adjusted OR, 0.48; 95% CI, 0.30-0.76). Moreover, the prevalence of oncogenic HPV types 16 or 18 (or both) was lower in pregnant women (P Å .015 and P Å .0018 respectively).
The association of human papillomavirus (HPV) infection
Materials and Methods with pregnancy has been the subject of many investigations, all
Patients. We recruited for the study a total of 1816 women, prompted by the long-standing clinical experience that genital all resident in the same geographic area, who were divided into 3 HPV-related lesions occur more frequently or worsen (or both) groups: group A, 752 pregnant women at term, consecutively obduring pregnancy and improve or regress after delivery [1] . In pregnant women [2] [3] [4] [5] [6] [7] [8] [9] [10] . Nonetheless, differences in methods group C, 560 symptomatic, nonpregnant women attending a vaginitis outpatient service in the same hospital (median age, 29.0 and strategies used for HPV detection, along with differences years; range, 19-47). All women were sexually active and were in study design, have led to conflicting results. Some authors enrolled from January 1995 through April 1996. All pregnant and found a higher HPV infection prevalence in pregnant than in nonpregnant women had no previous history of cervical dysplasia, nonpregnant women [3, 4, 10] , which suggested that pregnancy normal Pap smears, and no evidence of genital HPV-related lesions might be an independent risk factor for the infection. Others at entry. At enrollment, 5 women (0.7%) were excluded from the reported a lower prevalence [5] in pregnant women or no differpregnant cohort, 9 (1.7%) from the family planning service cohort, ence [6] [7] [8] [9] . and 39 (6.5%) from the vaginitis clinic cohort because of the To establish whether pregnancy influences HPV infection presence of visible warts or abnormal cervical cytology. To ascerprevalences, we studied, by polymerase chain reaction (PCR), tain social background and education, reproductive history, and cervicovaginal lavages from a large series of women, all pregsexual and smoking habits, all women were interviewed by trained nant and at term. The results were compared with those from personnel. Social class was ranked into 5 categories on the basis of the occupation of the subjects or their relatives (or both).
2 age-matched sets of nonpregnant women, 1 attending a family analysis, since ú60% of pregnant women refused to answer any (or both), however, was higher in nonpregnant subjects (P Å question regarding their sexual history.
.015).
In the second age-matched set, the overall prevalence of HPV infection was significantly higher in the patients attending Results a vaginitis clinic (13.8%) than in pregnant women (7.4%). The crude OR was 0.47, and after adjustment for confounders, the The overall prevalence of HPV infection was 5.4% (41/752) in pregnant women (group A), 11.3% (57/504) in nonpregnant likelihood of HPV infection was 50% lower in pregnant women than in matched symptomatic patients (OR, 0.48). The prevawomen attending a family planning service (group B; OR, 0.45; CI, 0.29-0.70), and 13.2% (74/560) in nonpregnant patients lence of HPV-16 or -18 (or both) was also higher in nonpregnant subjects (P Å .0018). attending a vaginitis clinic (group C; OR, 0.38; CI, 0.25-0.57). HPV-16 or -18 DNA (or both) was identified in 0.9% (7/752) in group A, 5.1% (26/504) in group B (OR, 0.17; CI, 0.06-Discussion 0.41), and 5.2% (29/560) in group C (OR, 0.17; CI, 0.06-0.40). Higher rates were detected in younger women, but the The effect of pregnancy on prevalence of HPV infection is still controversial. Direct comparisons between the numerous data did not reach statistical significance (test for trend, group A: 2.32, 1 df, P Å .128; group B: 0.4, 1 df, P Å .848; group reports on this issue are full of inconsistencies as to methodologies used for HPV detection, populations sampled, and criteria C: 0.44, 1 df, P Å .506). In group C, the prevalence of HPV infection was 12.5% (28/224) in subjects with a definite microfor inclusion in the given studies. Establishing HPV prevalence requires highly sensitive and specific techniques, and at present, biologic diagnosis of non-sexually transmitted genital infection (e.g., Candida vaginalis, bacterial vaginosis) and 21.7%
only PCR meets such requirements. Using this method, we found an overall 5.4% HPV prevalence in pregnant women, in (15/69) in subjects with sexually transmitted diseases (e.g., Trichomonas vaginalis, Chlamydia trachomatis, herpes geniwhom HPV-16 or -18 (or both) accounted for 17% of those. Our results matched those of de Roda Husman et al.
[8], who talis; P Å .06).
The prevalence of HPV infection was not influenced by used the same molecular method to investigate cytomorphologically normal pregnant women. the number of pregnancies, whereas a significant linear trend between HPV infection and low social class was identified in Apart from differences in detection techniques, the population samples investigated by the various authors carry diverse the vaginitis clinic cohort (x 2 for linear trend Å 4.6, P Å .031). Moreover, in groups A and C, the prevalence of HPV infection frequencies of risk factors for HPV infection, which have to be considered in any appropriate statistical analysis. Kemp et was higher in smokers (group A: 11/91 smokers vs. 30/661 nonsmokers, x 2 Å 8.84, P Å .003; group C: 35/192 smokers al. [7] found HPV prevalences of up to 42% in a cohort of pregnant women with a high incidence of sexually transmitted vs. 39/368 nonsmokers; x 2 Å 6.41, P Å .011) and in groups B and C, the rate of HPV infection was strongly influenced by diseases. Probably for the same reason, previous studies that used hybridization methods, none of which is as sensitive as the number of lifetime sex partners. In particular, the prevalence of HPV infection in subjects who reported more than PCR, reported figures of up to 46% [4] . Furthermore, most investigators did not make sure that cervifive lifetime sex partners was 23.5% (12/51) in group B and 24.6% (33/134) in group C compared with 9.9% (group B, 45/ covaginal samples were collected in the same trimester of preg- nancy. Detectable levels of HPV DNA have been shown both The features of HPV infection observed in our series were consistent with those from others, who reported a dependence of to vary during pregnancy [3, 4, 6, 8] and to peak in the third trimester [4, 6] , because of an increase in the viral replication HPV prevalence rates on age, low social class, smoking habits, and level of sexual promiscuity in the general population. activity [14] . Therefore, cervicovaginal sampling should be performed in standardized periods and sample collection should
We used a case-control analysis on age-matched sets to calculate the likelihood of HPV infection in pregnant women take place late in the pregnancy. 
